| Literature DB >> 27506138 |
Ana Virgínia Matos Sá Barreto1, Glaucia Alyne Nunes de Lacerda1, Anna Lígia de Castro Figueiredo1, George Tadeu Nunes Diniz1, Elainne Christine Souza Gomes1, Ana Lúcia Coutinho Domingues2, Constança Simões Barbosa1, Silvia Maria Lucena Montengro1, Clarice Neuenschwander Lins de Morais3.
Abstract
Serum levels of IL-9 and IL-17 cytokines were evaluated in patients in the acute, chronic phases and clinical forms of human schistosomiasis and in different classifications of periportal fibrosis. No significant differences between the groups of the disease with serum levels of cytokine were found. However, this study discusses the results of some cytokines that have not fully defined roles in the pathology of human schistosomiasis. Furthermore, an examination was made of subjects in the acute phase. This is an important group that is difficult to identify in areas where the disease is endemic. More studies are being undertaken to study the role of IL-9 and IL-17 in human Schistosoma mansoni infection and their relationship with the immunopathogenesis of disease.Entities:
Keywords: Evaluation; Interleukin-17; Interleukin-9; Schistosomiasis mansoni
Mesh:
Substances:
Year: 2016 PMID: 27506138 DOI: 10.1016/j.imbio.2016.07.014
Source DB: PubMed Journal: Immunobiology ISSN: 0171-2985 Impact factor: 3.144